PembrolizumabCytokine release syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1939卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31784-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：376 / 376

相关论文

共 50 条

[21] CytarabineCytokine release syndrome: case report
Reactions Weekly, 2024, 2023 (1) : 128 - 128
[22] TislelizumabCytokine release syndrome: case report
Reactions Weekly, 2025, 2041 (1) : 385 - 385
[23] AntineoplasticsCytokine release syndrome: case report
Reactions Weekly, 2021, 1853 (1) : 48 - 48
[24] NivolumabCytokine release syndrome: case report
Reactions Weekly, 2020, 1787 (1) : 391 - 391
[25] NivolumabCytokine release syndrome: case report
Reactions Weekly, 2022, 1902 (1) : 346 - 346
[26] BlinatumomabCytokine release syndrome: case report
Reactions Weekly, 2025, 2051 (1) : 67 - 67
[27] AlemtuzumabCytokine release syndrome: case report
Reactions Weekly, 2015, 1540 (1) : 21 - 21
[28] RituximabCytokine release syndrome: case report
Reactions Weekly, 2020, 1822 (1) : 253 - 253
[29] TisagenlecleucelCytokine release syndrome: case report
Reactions Weekly, 2018, 1727 (1) : 267 - 267
[30] TisagenlecleucelCytokine release syndrome: case report
Reactions Weekly, 2023, 1944 (1) : 527 - 527

← 1 2 3 4 5 →